| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-04-28 15:28:05 UTC |
|---|
| Updated at | 2022-04-28 15:28:05 UTC |
|---|
| NP-MRD ID | NP0070196 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Nigellidine |
|---|
| Description | Nigellidine belongs to the class of organic compounds known as pyridazinoindazoles. Pyridazinoindazoles are compounds containing a pyridazinoindazole moiety, which consists of a pyridazine ring fused to an indazole. Nigellidine is found in Nigella sativa . Nigellidine was first documented in 2021 (PMID: 34221083). Based on a literature review a small amount of articles have been published on Nigellidine (PMID: 35355337) (PMID: 34937447) (PMID: 34886775) (PMID: 34518755). |
|---|
| Structure | CC1=CC(=O)C2=C(N3CCCCN3C2=C1)C1=CC=C(O)C=C1 InChI=1S/C18H18N2O2/c1-12-10-15-17(16(22)11-12)18(13-4-6-14(21)7-5-13)20-9-3-2-8-19(15)20/h4-7,10-11,21H,2-3,8-9H2,1H3 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C18H18N2O2 |
|---|
| Average Mass | 294.3540 Da |
|---|
| Monoisotopic Mass | 294.13683 Da |
|---|
| IUPAC Name | 11-(4-hydroxyphenyl)-3-methyl-1H,6H,7H,8H,9H-pyridazino[1,2-a]indazol-1-one |
|---|
| Traditional Name | 11-(4-hydroxyphenyl)-3-methyl-6H,7H,8H,9H-pyridazino[1,2-a]indazol-1-one |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC1=CC(=O)C2=C(N3CCCCN3C2=C1)C1=CC=C(O)C=C1 |
|---|
| InChI Identifier | InChI=1S/C18H18N2O2/c1-12-10-15-17(16(22)11-12)18(13-4-6-14(21)7-5-13)20-9-3-2-8-19(15)20/h4-7,10-11,21H,2-3,8-9H2,1H3 |
|---|
| InChI Key | HJKNBAAMIKPHJF-UHFFFAOYSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as pyridazinoindazoles. Pyridazinoindazoles are compounds containing a pyridazinoindazole moiety, which consists of a pyridazine ring fused to an indazole. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Benzopyrazoles |
|---|
| Sub Class | Indazoles |
|---|
| Direct Parent | Pyridazinoindazoles |
|---|
| Alternative Parents | |
|---|
| Substituents | - Pyridazinoindazole
- Phenylpyrazole
- Phenol
- 1-hydroxy-2-unsubstituted benzenoid
- Monocyclic benzene moiety
- Pyridazine
- Benzenoid
- Vinylogous amide
- Azole
- Pyrazole
- Heteroaromatic compound
- Azacycle
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Organooxygen compound
- Organonitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Tegen D, Dessie K, Damtie D: Candidate Anti-COVID-19 Medicinal Plants from Ethiopia: A Review of Plants Traditionally Used to Treat Viral Diseases. Evid Based Complement Alternat Med. 2021 Jun 4;2021:6622410. doi: 10.1155/2021/6622410. eCollection 2021. [PubMed:34221083 ]
- Gonzalez BL, de Oliveira NC, Ritter MR, Tonin FS, Melo EB, Sanches ACC, Fernandez-Llimos F, Petruco MV, de Mello JCP, Chierrito D, de Medeiros Araujo DC: The naturally-derived alkaloids as a potential treatment for COVID-19: A scoping review. Phytother Res. 2022 Mar 30. doi: 10.1002/ptr.7442. [PubMed:35355337 ]
- Banerjee A, Kanwar M, Das Mohapatra PK, Saso L, Nicoletti M, Maiti S: Nigellidine (Nigella sativa, black-cumin seed) docking to SARS CoV-2 nsp3 and host inflammatory proteins may inhibit viral replication/transcription and FAS-TNF death signal via TNFR 1/2 blocking. Nat Prod Res. 2022 Nov;36(22):5817-5822. doi: 10.1080/14786419.2021.2018430. Epub 2021 Dec 22. [PubMed:34937447 ]
- Saha S, Pal D, Nimse SB: Indazole Derivatives Effective against Gastrointestinal Diseases. Curr Top Med Chem. 2022;22(14):1189-1214. doi: 10.2174/1568026621666211209155933. [PubMed:34886775 ]
- Mir SA, Firoz A, Alaidarous M, Alshehri B, Bin Dukhyil AA, Banawas S, Alsagaby SA, Alturaiki W, Bhat GA, Kashoo F, Abdel-Hadi AM: Identification of SARS-CoV-2 RNA-dependent RNA polymerase inhibitors from the major phytochemicals of Nigella sativa: An in silico approach. Saudi J Biol Sci. 2022 Jan;29(1):394-401. doi: 10.1016/j.sjbs.2021.09.002. Epub 2021 Sep 8. [PubMed:34518755 ]
|
|---|